CN116286880B - 一种过氧化物酶体增值因子基因RkPEX11及其用途 - Google Patents
一种过氧化物酶体增值因子基因RkPEX11及其用途 Download PDFInfo
- Publication number
- CN116286880B CN116286880B CN202310090676.3A CN202310090676A CN116286880B CN 116286880 B CN116286880 B CN 116286880B CN 202310090676 A CN202310090676 A CN 202310090676A CN 116286880 B CN116286880 B CN 116286880B
- Authority
- CN
- China
- Prior art keywords
- gene
- rkpex
- rhodosporidium
- carotenoid
- peroxisome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 31
- 210000002824 peroxisome Anatomy 0.000 title claims abstract description 19
- 235000021466 carotenoid Nutrition 0.000 claims abstract description 42
- 150000001747 carotenoids Chemical class 0.000 claims abstract description 42
- 241000223252 Rhodotorula Species 0.000 claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 241000007100 Rhodotorula kratochvilovae Species 0.000 claims abstract description 7
- 239000002773 nucleotide Substances 0.000 claims abstract description 6
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 6
- 230000035755 proliferation Effects 0.000 claims description 8
- 239000003614 peroxisome proliferator Substances 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 15
- 238000003786 synthesis reaction Methods 0.000 abstract description 13
- 230000002018 overexpression Effects 0.000 abstract description 7
- 230000006872 improvement Effects 0.000 abstract description 5
- 244000005700 microbiome Species 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract description 2
- 230000009466 transformation Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 230000003321 amplification Effects 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 238000012163 sequencing technique Methods 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000004992 fission Effects 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 101150015692 PEX11A gene Proteins 0.000 description 3
- 102100040056 Peroxisomal membrane protein 11A Human genes 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 101150107962 pex11 gene Proteins 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000223254 Rhodotorula mucilaginosa Species 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000576 food coloring agent Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000000214 effect on organisms Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种过氧化物酶体增值因子基因RkPEX11,其核苷酸序列如SEQ ID NO:1所示,该基因编码的氨基酸序列如SEQ ID NO:2所示,该基因是红冬孢酵母(Rhodosporidium kratochvilovae)YM25235中获得的,将该基因通过转化转入到红冬孢酵母YM25235中,实验结果显示RkPEX11基因的过表达会促进YM25235菌株中类胡萝卜素合成水平的提高;本发明通过基因工程手段对微生物进行改造,来提高微生物体内类胡萝卜素的产量,为类胡萝卜素大规模商业化生产奠定基础。
Description
技术领域
本发明属于生物技术领域和遗传工程领域,涉及一种过氧化物酶体增值因子基因RkPEX11,具体涉及从红冬孢酵母(Rhodosporidium kratochvilovae)YM25235中克隆的过氧化物酶体增值因子基因RkPEX11以及将该基因直接与不同载体连接,转入酵母细胞,提高该基因在酵母里的表达水平并最终促进类胡萝卜素的合成。
背景技术
过氧化物酶体增值因子PEX11是一种过氧化物酶体扩增蛋白(即参与过氧化物酶体生物发生或组织的蛋白质),其活性是过氧化物酶体增殖期间单个过氧化物酶体膜的管状和裂变所必需的。它是过氧化物酶体增殖非诱导条件下表达最高的过氧化物酶,也是最丰富的过氧化物酶体膜蛋白。PEX11被证明它招募了线粒体裂变机制,该机制也负责新形成的过氧化物酶体的裂变。酿酒酵母的PEX11已被证明可以募集线粒体裂变机制到过氧化物酶体中,从而使过氧化物酶体的增殖成为可能,这个过程对于有效的脂肪酸β氧化至关重要。
类胡萝卜素(carotenoid)是所有光合生物及一些非光合原核生物和真菌合成的一类重要的天然色素的总称,属于类萜化合物,普遍存在于动物、高等植物、真菌、藻类中。典型的类胡萝卜素是由8个异戊二烯单元首尾相连而成的C40萜类化合物及其衍生物,其结构中的共轭双键的作用导致其各种类胡萝卜素的颜色差异。天然类胡萝卜素对于生物体具有十分广泛的作用。类胡萝卜素是人体内维生素A的主要来源,同时还具有抗氧化、免疫调节、抗癌、延缓衰老等功效,对视觉系统有保健作用,可预防夜盲症、干眼症、角膜溃疡症等病症;对皮肤组织的保健,维生素A是维持一切上皮组织完整所必需的,而β-胡萝卜能在人体内转化成维生素A,维持正常的体表、消化道、呼吸道、生殖泌尿道有重要意义,可避免皮肤多屑、角质化、表皮细胞硬鳞状、多角质血疹性皮肤干燥症等皮肤疾病。β-胡萝卜素对细胞膜的稳定性也具有良好的作用,抵抗不良环境等。在工业上类胡萝卜素被用作食品着色剂、营养强化剂和抗氧化剂等。叶黄素可作为食品着色剂用于面条、色拉调味品等食品中;在一些调味品中,利用番茄红素具有超强的抗氧化活性,代替亚硝酸盐防止食物腐败变质,有效的延长保质期。
随着人们对天然类胡萝卜素制品的需求量的增加,天然类胡萝卜素的产量与质量已无法满足市场需求。目前,类胡萝卜素的生产方法主要包括植物提取法、化学合成法和生物合成法。在食品工业中,合成化合物带来了许多负面影响,合成食品安全问题越来越受到社会的关注。而且由于存在生物活性低且生成色素有一定的毒副作用,已被许多国家和地区限制使用;植物提取法由于植物中类胡萝卜素含量较低,提取成本比较高、工艺又复杂等原因,使用也较少;而生物合成法提取的类胡萝卜素是纯天然的,对人体安全无毒副作用,因此用生物合成法提取类胡萝卜素是目前最具发展潜力的一种提取方法。目前来说,能够发酵产生类胡萝卜素的微生物主要有真菌、细菌和酵母菌等,其中利用酵母发酵生产类胡萝卜素的研究最为常见,且酵母属于我国饲料行业中确认的饲用微生物。因此,以酵母为生产菌种用微生物发酵法来生产天然类胡萝卜素从而满足人们的需求是一条十分可行的道路。
在发酵工艺中,提高类胡萝卜素合成底物-乙酰辅酶A是促进类胡萝卜素合成的有效方法。因为红酵母具有营养要求简单、生产周期短等许多优点,被大量用于研究生产类胡萝卜素,可用于生产类胡萝卜素的红酵母主要集中于胶红酵母、粘红酵母、深红酵母、法夫红酵母、小红酵母五种。通过诱变改良菌种、发酵工艺优化等手段使得红酵母的类胡萝卜素产量进行提升一直受到研究者的广泛关注。
目前尚未见过氧化物酶体增值因子基因在促进酵母菌生产类胡萝卜素的相关报道。
发明内容
本发明提供了一种过氧化物酶体增值因子基因RkPEX11,该基因是从红冬孢酵母(Rhodosporidium kratochvilovae)YM25235中分离得到,该基因核苷酸序列如SEQ ID NO:1所示或为该核苷酸序列的片段,或与SEQ ID NO:1互补的核苷酸序列,该基因序列长为735bp(碱基),该基因编码的氨基酸序列如SEQ ID NO:2所示的多肽或其片段。
本发明目的通过以下技术方案实现:
1、从红冬孢酵母(Rhodosporidium kratochvilovae)YM25235中扩增获得过氧化物酶体增值因子基因RkPEX11;
2、过氧化物酶体增值因子基因RkPEX11连接到表达载体 pRH2034上获得重组过表达质粒;
3、将重组过表达质粒pRHRkPEX11转化至红冬孢酵母YM25235中用于生产类胡萝卜素。
本发明的优点和技术效果:
本发明从红冬孢酵母(Rhodosporidium kratochvilovae)YM25235的总RNA基因中获得的过氧化物酶体增值因子基因RkPEX11在红冬孢酵母YM25235中过表达,会引起细胞内这个基因的转录水平的提高,说明外源基因在菌体内发生转录,继而翻译成相应蛋白,使得酵母内的过氧化物酶体增值,进而促进了脂肪酸的β氧化,产生大量的乙酰辅酶A,引起细胞内与类胡箩卜素合成相关的酶的表达量的提高。本研究结果有助于阐明红冬孢酵母YM25235中产类胡萝卜素机制,有助于通过基因工程手段对其进行改造来提高类胡萝卜素含量,对类胡萝卜素的工业化生产提供有良好的应用前景和经济效益,为生物合成法生产类胡萝卜素提供理论支持。
附图说明
图1为本发明的红冬孢酵母YM25235的RkPEX11基因PCR扩增图;
图2为重组质粒pRHRkPEX112的质粒图谱;
图3为重组质粒pRHRkPEX11转化红冬孢酵母YM25235的PCR验证;其中1、DNA 分子标量DL2000;2、空白对照组(未添加模板); 3、以YM25235基因组为模板的PCR产物(含有内含子);4、以质粒pRHRkPEX11为模板的PCR产物,5、以YM25235/pRHRkPEX11-11菌株基因组为模板的PCR产物;
图4为过表达菌株YM25235/pRHRkPEX11与对照菌株YM25235/pRH2034的总类胡萝卜素含量。
具体实施方式
下面结合附图和实施例对本发明作进一步详细说明,但本发明保护范围不局限于所述内容,实施例中使用的试剂和方法,如无特殊说明,均采用常规试剂和使用常规方法。
实施例1:从红冬孢酵母(Rhodosporidium kratochvilovae)YM25235中分离获取过氧化物酶体增值因子基因RkPEX11
采用生工生物工程(上海)股份有限公司的UNlQ-10 柱式 Trizol 总RNA抽提试剂盒(产品编号: SK1321)提红冬孢酵母YM25235的总RNA ,然后采用TaKaRa公司试剂盒PrimeScript ®RT reagent Kit With gDNA Eraser(Perfect Real Time)进行反转录合成cDNA,取0.5μL cDNA为模板进行聚合酶链式反应,根据转录组测序中发现的RkPEX11序列,设计特异性引物RkPEX11-F和RkPEX11-R,以上述得到的cDNA模板在PCR仪(BIOER公司)上进行PCR扩增,反应所用引物、扩增体系和扩增条件如下:
RkPEX11-F:5’-ATCACTCACCATGGCGGATCCGATGACCGTCGTTCACCAGC-3’
RkPEX11-R:5’-CCGGTCGGCATCTACGATATCCTACTTGCTGGCGCCGAG-3’ ;
(GATCCG为BamH I酶切位点,GATATC为EcoR V酶切位点);
PCR扩增体系如下(50μL):
扩增条件为:94℃预变性5min,再用94℃变性30s,58℃退火30s,72℃延伸1min,进行30个循环,最后72℃彻底延伸10min,反应完后取产物2μL,然后在浓度为1%的琼脂糖凝胶中进行电泳分析,结果如图1所示,扩增得到大小约750bp的片段,用琼脂糖凝胶DNA回收试剂盒(北京索莱宝科技有限公司)回收,把回收片段连接至到pMD-18T(TaKaRa公司产品)中,连接产物转化到感受态大肠杆菌DH5α,在含氨苄青霉素(100µg/mL)的LB固体平板上过夜培养,通过菌落PCR验证阳性克隆。将验证阳性的克隆子接入LB液体培养基(含100µg/mL氨苄青霉素)中过夜培养,用高纯质粒小量制备试剂盒(离心柱型)(北京百泰克生物技术有限公司)提取质粒,测序(昆明硕擎生物科技有限公司),测序结果显示所扩增得到的片段大小为735bp,将获得的片段命名为RkPEX11,核苷酸序列如SEQ ID NO:1所示。
实施例2:过表达载体pRHRkPEX11的构建
以反转录的YM25235 cDNA 为模板,用RkPEX11-F 和RkPEX11-R 作为引物扩增RkPEX11的编码序列,获得的RkPEX11片段大小约735bp,将扩增获得的RkPEX11片段与被BamH I、EcoRⅤ两个限制性内切酶进行酶切后的载体连接,连接到表达载体 pRH2034上获得重组质粒pRHRkPEX11(图2)。将获得的重组质粒转入感受态大肠杆菌 DH5α中扩增,经菌落 PCR 验证后提取重组质粒;用测序引物进行测序。测序结果表明,测序所获得的序列与目的序列完全一致,没有出现任何碱基突变和缺失等。
实施例3:RkPEX11基因与红冬孢酵母中类胡萝卜素合成关系的分析
1、转化红冬孢酵母YM25235
利用农杆菌介导法将重组质粒pRHRKPEX11转化至红冬孢酵母YM25235中,以含潮霉素B(终浓度为150µg/mL)的YPD培养基筛选转化子,然后按照上海生工生物工程股份有限公司DNA提取试剂盒说明书中步骤提取酵母转化子的基因组 DNA,后进行PCR验证,结果如图3所示。
2、红冬孢酵母中类胡萝卜素含量检测
将含pRHRkPEX11的过表达菌株在28℃条件下培养168 h后,提取类胡萝卜素,并以转入空质粒pRH2034的红冬孢酵母菌株为对照,紫外-可见分光光度计在445nm下测定总类胡萝卜素的含量(mg/g干菌体),结果如图4所示;结果表明,过表达菌株YM25235/pRHRkPEX11的总类胡萝卜素合成量相较于含空质粒pRH2034的对照菌株有着明显提高,含空质粒pRH2034的对照菌株的类胡萝卜素合成量为4.99mg/g,而过表达菌株YM25235/pRHRkPEX11类胡萝卜素合成量为9.88mg/g,即过表达菌株YM25235/pRHRkPEX11类胡萝卜素合成量是对照菌的1.97倍,证明了RkPEX11基因能够促进总类胡萝卜素的合成。
Claims (2)
1.一种过氧化物酶体增值因子基因RkPEX11,其核苷酸序列如SEQ ID NO:1所示。
2.权利要求1所述的过氧化物酶体增值因子基因RkPEX11在促进红冬孢酵母(Rhodosporidium kratochvilovae)生产类胡萝卜素中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310090676.3A CN116286880B (zh) | 2023-02-09 | 2023-02-09 | 一种过氧化物酶体增值因子基因RkPEX11及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310090676.3A CN116286880B (zh) | 2023-02-09 | 2023-02-09 | 一种过氧化物酶体增值因子基因RkPEX11及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116286880A CN116286880A (zh) | 2023-06-23 |
CN116286880B true CN116286880B (zh) | 2024-04-30 |
Family
ID=86780604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310090676.3A Active CN116286880B (zh) | 2023-02-09 | 2023-02-09 | 一种过氧化物酶体增值因子基因RkPEX11及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116286880B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116286900B (zh) * | 2022-10-28 | 2024-04-26 | 昆明理工大学 | 一种乙酸渗透酶A基因RkAcpa及其应用 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006091924A2 (en) * | 2005-02-24 | 2006-08-31 | Regents Of The University Of Minnesota | Producing carotenoids |
CN101180396A (zh) * | 2004-10-15 | 2008-05-14 | 帝斯曼知识产权资产管理有限公司 | 在真核细胞中生产化合物的方法 |
CN105189731A (zh) * | 2012-12-19 | 2015-12-23 | 沃德金有限公司 | 制备脂肪二羧酸的生物学方法 |
CN109666683A (zh) * | 2019-02-27 | 2019-04-23 | 昆明理工大学 | 乙酰辅酶A乙酰转移酶基因RKAcaT2及其应用 |
CN109890832A (zh) * | 2016-06-06 | 2019-06-14 | 普罗维维股份有限公司 | 脂肪醇和脂肪醛的半生物合成产生 |
WO2019132510A2 (ko) * | 2017-12-27 | 2019-07-04 | 아주대학교산학협력단 | 세포 소기관이 변이된 재조합 효모 및 이를 이용한 아이소프레노이드 생산 방법 |
EP3652192A1 (en) * | 2017-07-13 | 2020-05-20 | Radici Chimica S.p.A. | Biological methods for preparing terpenes |
CN113621631A (zh) * | 2021-08-11 | 2021-11-09 | 昆明理工大学 | 一种甲羟戊酸激酶基因rkmk及其应用 |
CN113652440A (zh) * | 2021-08-05 | 2021-11-16 | 昆明理工大学 | 3-酮脂酰辅酶a硫解酶基因rkacaa1-2及其应用 |
CN116286900A (zh) * | 2022-10-28 | 2023-06-23 | 昆明理工大学 | 一种乙酸渗透酶A基因RkAcpa及其应用 |
-
2023
- 2023-02-09 CN CN202310090676.3A patent/CN116286880B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101180396A (zh) * | 2004-10-15 | 2008-05-14 | 帝斯曼知识产权资产管理有限公司 | 在真核细胞中生产化合物的方法 |
WO2006091924A2 (en) * | 2005-02-24 | 2006-08-31 | Regents Of The University Of Minnesota | Producing carotenoids |
CN105189731A (zh) * | 2012-12-19 | 2015-12-23 | 沃德金有限公司 | 制备脂肪二羧酸的生物学方法 |
CN109890832A (zh) * | 2016-06-06 | 2019-06-14 | 普罗维维股份有限公司 | 脂肪醇和脂肪醛的半生物合成产生 |
EP3652192A1 (en) * | 2017-07-13 | 2020-05-20 | Radici Chimica S.p.A. | Biological methods for preparing terpenes |
WO2019132510A2 (ko) * | 2017-12-27 | 2019-07-04 | 아주대학교산학협력단 | 세포 소기관이 변이된 재조합 효모 및 이를 이용한 아이소프레노이드 생산 방법 |
CN109666683A (zh) * | 2019-02-27 | 2019-04-23 | 昆明理工大学 | 乙酰辅酶A乙酰转移酶基因RKAcaT2及其应用 |
CN113652440A (zh) * | 2021-08-05 | 2021-11-16 | 昆明理工大学 | 3-酮脂酰辅酶a硫解酶基因rkacaa1-2及其应用 |
CN113621631A (zh) * | 2021-08-11 | 2021-11-09 | 昆明理工大学 | 一种甲羟戊酸激酶基因rkmk及其应用 |
CN116286900A (zh) * | 2022-10-28 | 2023-06-23 | 昆明理工大学 | 一种乙酸渗透酶A基因RkAcpa及其应用 |
Non-Patent Citations (5)
Title |
---|
Fakankun,I.U.等.peroxisomal biogenesis factor 11 [Rhodotorula diobovata].Genbank Database.2019,Accession No:TNY22084.1. * |
Firrincieli,A.等.Rhodotorula graminis WP1 uncharacterized protein (RHOBADRAFT_12042), partial mRNA.Genbank Database.2020,Accession No:XM_018412075.1. * |
Genome-Wide Localization Study of Yeast Pex11 Identifies Peroxisome-Mitochondria Interactions through the ERMES Complex;Mattiazzi Ušaj M等;J Mol Biol.;20150605;第72-87页 * |
植物响应盐碱胁迫的机制;毛恋;芦建国;江海燕;;分子植物育种;20190530(第10期);第1-8页 * |
植物过氧化物酶体蛋白的系统挖掘及过氧化物酶体蛋白HRLP的功能机制探究;张钰婵;中国知网;20231231;第1-184页 * |
Also Published As
Publication number | Publication date |
---|---|
CN116286880A (zh) | 2023-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109666683B (zh) | 乙酰辅酶A乙酰转移酶基因RKAcaT2及其应用 | |
CN112410355B (zh) | 一种酰基辅酶a氧化酶2基因rkacox2及其应用 | |
KR102202606B1 (ko) | 바이오레티놀을 생산하는 미생물 및 이를 이용한 바이오레티놀의 생산방법 | |
CN110747206B (zh) | 3-羟基-3-甲基戊二酸单酰辅酶a还原酶基因rkhmgr及其应用 | |
CN113430215B (zh) | 乙酰CoA合成酶基因RKACS1及其应用 | |
CN109777815B (zh) | HMG-CoA合成酶基因RKHMGCS及其应用 | |
CN106318878B (zh) | 一种高产虾青素红酵母工程菌及其构建方法 | |
AU2017383475B2 (en) | Genetically engineered candida utilis capable of degrading and utilizing kitchen waste and construction method therefor | |
CN116286880B (zh) | 一种过氧化物酶体增值因子基因RkPEX11及其用途 | |
CA2974539A1 (en) | Modified glucoamylase enzymes and yeast strains having enhanced bioproduct production | |
CN110106206B (zh) | 一种提高l-赖氨酸产量及稳定性的谷氨酸棒状杆菌构建方法 | |
CN113621630B (zh) | 3-酮脂酰-CoA硫解酶基因RkACAA1-1及其应用 | |
Chien et al. | Solar-to-bioH2 production enhanced by homologous overexpression of hydrogenase in green alga Chlorella sp. DT | |
CN111454854B (zh) | 一株产虾青素的红冬孢酵母基因工程菌株 | |
CN115011616B (zh) | 一种乙醛脱氢酶基因rkaldh及其应用 | |
US11702627B2 (en) | High cAMP yielding yeast strain and use thereof | |
CN109536518A (zh) | 一种八氢番茄红素脱氢酶基因RKcrtI及其应用 | |
CN104651287A (zh) | 一种用于合成甘油葡糖苷的工程菌和应用 | |
CN107287222B (zh) | 一种组氨酸激酶基因Hisk2301的用途 | |
CN114250240B (zh) | 一种调节大肠杆菌菌膜形态和高效合成mk-7的方法 | |
CN112608936B (zh) | 调控酵母外源基因表达的启动子,调控方法及其应用 | |
CN110592084B (zh) | 一种rhtA基因启动子改造的重组菌株及其构建方法与应用 | |
CN104278015B (zh) | 一株高效过表达内源虾青素合成酶基因的法夫酵母菌株 | |
CN109055417B (zh) | 一种重组微生物、其制备方法及其在生产辅酶q10中的应用 | |
CN108624600B (zh) | 锌指转录因子基因RkMsn4的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |